Clinical Trial Update: Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial updating comparison of two solvents used with a chemotherapy agent for transarterial chemoembolization in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED